openPR Logo
Press release

Anti-infective Drugs Market to Reach USD 169.5 Billion in 2024

11-01-2019 07:32 AM CET | Health & Medicine

Press release from: Fast Market Research

Anti-infective Drugs Market to Reach USD 169.5 Billion in 2024

Fast.MR has presented a detailed report on “Anti-infective Drugs Market – By Product Type (Anti-bacterial Drugs, Anti-fungal Drugs, and Anti-viral Drugs), By Indication (Pneumonia, Methicillin-resistant Staphylococcus Aureus, Sepsis, Tuberculosis, Dermatophytosis, Aspergillosis, Candidiasis, Hepatitis Virus Infection, HIV Infection and Respiratory Virus Infection) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales) – Global Market Analysis, Trends, Opportunity and Forecast, 2018-2024” which includes the major application, advantages, and key market trends that are fostering the growth of the market during the forecasted span of 6 years. The research takes a step forward and analyzes the key competitors and global regions that are holding the market share of Anti-infective Drugs Market in terms of revenue.

Global anti-infective drugs market is estimated to reach USD 169.5 Billion in 2024, registering a compound annual growth rate (CAGR) of 4.1% between 2019 and 2024. Growing number of anti-infection treatment and procedures is one of the key factors which is driving the growth of global anti-infective drugs market.

Get Sample Copy of This Report- https://www.fastmr.com/request-s/70

Market Insights

Growth Drivers – Anti-infective Drugs Market

Rising Penetration of Infectious Diseases

Increasing prevalence of infectious disease such as malaria, HIV, Ebola among others is expected to foster the growth of global anti-infective drugs market during the forecast period. Additionally, increasing awareness about infectious disease among people is believed to positively impact the growth of global anti-infective drugs market.

Favorable government initiatives such as awareness campaigns and reimbursement policies are also expanding the scope of growth of market players. Moreover, various companies are actively engaged in advanced drug discovery. This factor is envisioned to bolster the growth of market.

Development of New Drugs

Continuous development and innovation of new drugs is anticipated to drive the growth of global anti-infective drugs market. Some companies with Phase 3 trials such as Iterum Therapeutics, Spero Therapeutics, Nabriva Therapeutics, and Tetraphase Pharmaceuticals are likely to get approval within 12 months. This will also lead to growth of global anti-infective drugs market.

Barriers – Anti-infective Drugs Market

Anti-infective Drugs Shortages

Transient shortage and long-terms shortage of anti-infective drugs is a major growth barrier in the global anti-infective drugs market. Apart from this, various major manufacturers are shutting down their antibiotic research and development which is further likely to negative impact the growth of global anti-infective drugs market.

Segmentation Analysis

The anti-infective drugs market by product type is segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In this segment, anti-viral drugs segment is anticipated to capture the largest market share in 2024.

Based on indication, the anti-infective drugs market is further sub segmented into pneumonia, methicillin-resistant staphylococcus aureus, sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection and respiratory virus infection. HIV captured significant market share in overall anti-infective drugs market in 2018.

Geographical Analysis

Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In anti-infective drugs market, North America dominated in 2018, acquiring significant portion of overall market. Factors such as increasing geriatric population and presence of advanced healthcare infrastructure are some of the major factors which are believed to bolster the growth of anti-infective drugs formula in North America. Asia Pacific anti-infective drugs market is expected to showcase highest growth rate during the forecast period. Presence of generic companies and increasing spending on healthcare is anticipated to positively impact the demand for Asia Pacific anti-infective drugs market.

Competitive Analysis

The report also covers detailed competitive analysis of major market players of global anti-infective drugs market, such as Gilead Sciences, GlaxoSmithKline plc, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Boehringer Ingelheim GmbH, Pfizer, Mylan N.V., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd and other prominent players. The anti-infective drugs market is witnessing a wide range of industry activities such as product launch, acquisition, partnership, and expansion across the globe.

Browse Complete Report With Table of Content@https://www.fastmr.com/report/70/anti-infective-drugs-market

Table of Content

1.Preface

1.1. Research Methodology

1.2. Geographic Scope

1.3. Years Considered

2.Executive Summary

3.Market Overview

3.1. Anti-infective Drugs Overview

3.2. Market Definition & Key Market Segments

3.3. Industry Development

3.4. Global Market Maturity

3.4.1. North America

3.4.2. Europe

3.4.3. Asia Pacific

3.4.4. Latin America

3.4.5. Middle East & Africa

3.5. Porter’s Five Force Analysis

3.6. Industry Value Chain Analysis

3.7. Macro-Economic Trends

4.Competitive Landscape

4.1. Global Anti-infective Drugs Market 2018

4.2. Global Anti-infective Drugs Market Value Share, By Company 2018

5.Growth Drivers & Barriers in Global Anti-infective Drugs Market

5.1. North America

5.2. Europe

5.3. Asia Pacific

5.4. Rest of World

6.Trends in Global Anti-infective Drugs Market

6.1. North America

6.2. Europe

6.3. Asia Pacific

6.4. Rest of World

7.Global Anti-infective Drugs Market

7.1. Introduction

7.2. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.Global Anti-infective Drugs Market Segmentation Analysis, By Product Type

8.1. Introduction

8.2. Strategic Insights

8.2.1. BPS Analysis, By Product Type

8.2.2. Market Attractiveness, By Product Type

8.3. Anti-bacterial Drugs

8.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.2. B-lactams

8.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.3. Quinolones

8.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.4. Macrolides

8.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.5. Tetracycline

8.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.6. Aminoglycoside

8.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.3.7. Others

8.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.4. Anti-fungal Drugs

8.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.4.2. Azoles

8.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.4.3. Echinocandins

8.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.4.4. Polyenes

8.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8.5. Anti-viral Drugs

8.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.Global Anti-infective Drugs Market Segmentation Analysis, By Indication

9.1. Introduction

9.2. Strategic Insights

9.2.1. BPS Analysis, By Indication

9.2.2. Market Attractiveness, By Indication

9.3. Pneumonia

9.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.4. Methicillin-resistant Staphylococcus Aureus (MRSA)

9.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.5. Sepsis

9.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.6. Tuberculosis

9.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.7. Dermatophytosis

9.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.8. Aspergillosis

9.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.9. Candidiasis

9.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.10. Hepatitis Virus Infection

9.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.11. HIV Infection

9.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9.12. Respiratory Virus Infection

9.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

10.Global Anti-infective Drugs Market Segmentation Analysis, By Distribution Channel

10.1. Introduction

10.2. Strategic Insights

10.2.1. BPS Analysis, By Distribution Channel

10.2.2. Market Attractiveness, By Distribution Channel

10.3. Hospital Pharmacy

10.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

10.4. Retail Pharmacy

10.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

10.5. Online Sales

10.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.Geographical Analysis

11.1. Introduction

11.2. North America Anti-infective Drugs Market

11.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2. By Product Type

11.2.2.1. Introduction

11.2.2.2. Strategic Insights

11.2.2.2.1. BPS Analysis, By Product Type

11.2.2.2.2. Market Attractiveness, By Product Type

11.2.2.3. Anti-bacterial Drugs

11.2.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.2. B-lactams

11.2.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.3. Quinolones

11.2.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.4. Macrolides

11.2.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.5. Tetracycline

11.2.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.6. Aminoglycoside

11.2.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.3.7. Others

11.2.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.4. Anti-fungal Drugs

11.2.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.4.2. Azoles

11.2.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.4.3. Echinocandins

11.2.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.4.4. Polyenes

11.2.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.2.5. Anti-viral Drugs

11.2.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3. By Indication

11.2.3.1. Introduction

11.2.3.2. Strategic Insights

11.2.3.2.1. BPS Analysis, By Indication

11.2.3.2.2. Market Attractiveness, By Indication

11.2.3.3. Pneumonia

11.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)

11.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.5. Sepsis

11.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.6. Tuberculosis

11.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.7. Dermatophytosis

11.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.8. Aspergillosis

11.2.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.9. Candidiasis

11.2.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.10. Hepatitis Virus Infection

11.2.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.11. HIV Infection

11.2.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.3.12. Respiratory Virus Infection

11.2.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.4. By Distribution Channel

11.2.4.1. Introduction

11.2.4.2. Strategic Insights

11.2.4.2.1. BPS Analysis, By Distribution Channel

11.2.4.2.2. Market Attractiveness, By Distribution Channel

11.2.4.3. Hospital Pharmacy

11.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.4.4. Retail Pharmacy

11.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.4.5. Online Sales

11.2.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.5. By Country

11.2.5.1. Introduction

11.2.5.2. Strategic Insights

11.2.5.2.1. BPS Analysis, By Country

11.2.5.2.2. Market Attractiveness, By Country

11.2.5.3. U.S. Anti-infective Drugs Market

11.2.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.2.5.4. Canada Anti-infective Drugs Market

11.2.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

More Info@@

Contact Us:

Jason Lee

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@fastmr.com

Website: www.fastmr.com

Follow Us – Facebook, Twitter, Linked In

About Us:

FAST. MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in depth to provide our clients with better strategies to stand out in the market

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-infective Drugs Market to Reach USD 169.5 Billion in 2024 here

News-ID: 1859539 • Views:

More Releases from Fast Market Research

Aerial Refueling Systems market projected a CAGR of 3.75% during the forecast period of 2019-2024
Aerial Refueling Systems market projected a CAGR of 3.75% during the forecast pe …
The Global Aerial Refueling Systems Market has reached USD 557.2 Million in 2019 and estimated to reach USD 669.7 Million in 2024 at a significant CAGR of 3.75% during the forecast period 2019-2024. The rising technology advancement is the major factor, which expected to boost the global Aerial Refueling Systems market during the forecast period of 2024 across the globe. The Aerial Refueling System can be identified as a means of
Night Cream Market Expected to Witness a significant growth over the forecast period 2025
Night Cream Market Expected to Witness a significant growth over the forecast pe …
Market Dynamics The consumer goods & retail industry has grown at a significant rate and is expected to achieve a notable position by the end of 2025. With the shift in the buying power of the consumers, the overall industry is expected to grow at a steady rate. Thus, consumers from the developing & emerging markets are focusing on spending considerably on personal & healthcare products, which illustrates that increased buying
Agricultural Robots Market: New Developments helps to grow market opportunities & forecast until 2024
Agricultural Robots Market: New Developments helps to grow market opportunities …
According to a recent report published by Fast. MR, titled, Global Agricultural Robots Market 2018: Market Size, Market Volume, Trends, Opportunity, Forecast 2018-2024, the global agricultural robots market accounted for USD XX Million in 2018 and is estimated to reach USD 16,182.9 Million by 2024. Moreover, it is anticipated to flourish at a CAGR of 20.8% during the forecast period i.e. 2019-2024. The global agricultural robots market has been segmented based
South Africa Office Furniture Market Demand, Growth, Opportunities, Top Key Players and Forecast to 2024
South Africa Office Furniture Market Demand, Growth, Opportunities, Top Key Play …
The market research report, from Fast.MR, studies the "South Africa Office Furniture Market" for the forecast period of 2019 to 2024 in terms of value. The South Africa Office Furniture Market research report will represent the analysis of all the segments, which will include the market size, Y-O-Y growth analysis and structure of the overall industry. The South Africa Office Furniture Market research report determines the market dynamics, which includes growth

All 4 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$